Advertisement
BDSX vs ELMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSX is a Hold and ELMD is a Hold.
Momentum Indicator for BDSX turns negative, indicating new downward trend
BDSX saw its Momentum Indicator move below the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In 78 of the 86 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
BDSX moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BDSX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDSX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BDSX entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +12.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDSX advanced for three days, in 202 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
BDSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.843) is normal, around the industry mean (67.298). P/E Ratio (-2.752) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.463) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating fairly steady price growth. BDSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
ELMD's Indicator enters downward trend
The Aroon Indicator for ELMD entered a downward trend on November 04, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 172 similar instances where the Aroon Indicator formed such a pattern. In 123 of the 172 cases the stock moved lower. This puts the odds of a downward move at 72%.
Technical Analysis (Indicators)
Bearish Trend Analysis
ELMD moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for ELMD moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ELMD's RSI Oscillator exited the oversold zone, 19 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 72 cases where ELMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ELMD as a result. In 89 of 118 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
Following a +3.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELMD advanced for three days, in 184 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
ELMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 42 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 52 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. ELMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.211) is normal, around the industry mean (4.142). P/E Ratio (19.832) is within average values for comparable stocks, (3.291). ELMD's Projected Growth (PEG Ratio) (103.010) is very high in comparison to the industry average of (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.080) is also within normal values, averaging (40.124).
BDSX | ELMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 52 Fair valued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 52 | |
SMR RATING 1..100 | 100 | 42 | |
PRICE GROWTH RATING 1..100 | 66 | 61 | |
P/E GROWTH RATING 1..100 | 9 | 80 | |
SEASONALITY SCORE 1..100 | 13 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDSX's Valuation (52) in the null industry is somewhat better than the same rating for ELMD (100) in the Medical Specialties industry. This means that BDSX’s stock grew somewhat faster than ELMD’s over the last 12 months.
ELMD's Profit vs Risk Rating (52) in the Medical Specialties industry is somewhat better than the same rating for BDSX (100) in the null industry. This means that ELMD’s stock grew somewhat faster than BDSX’s over the last 12 months.
ELMD's SMR Rating (42) in the Medical Specialties industry is somewhat better than the same rating for BDSX (100) in the null industry. This means that ELMD’s stock grew somewhat faster than BDSX’s over the last 12 months.
ELMD's Price Growth Rating (61) in the Medical Specialties industry is in the same range as BDSX (66) in the null industry. This means that ELMD’s stock grew similarly to BDSX’s over the last 12 months.
BDSX's P/E Growth Rating (9) in the null industry is significantly better than the same rating for ELMD (80) in the Medical Specialties industry. This means that BDSX’s stock grew significantly faster than ELMD’s over the last 12 months.
| BDSX | ELMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 68% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 71% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 75% |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 67% |
| Advances ODDS (%) | 13 days ago 85% | 13 days ago 70% |
| Declines ODDS (%) | 5 days ago 90% | 8 days ago 66% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 75% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 72% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDSX’s FA Score shows that 1 FA rating(s) are green while ELMD’s FA Score has 0 green FA rating(s).
- BDSX’s FA Score: 1 green, 4 red.
- ELMD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDSX’s TA Score shows that 4 TA indicator(s) are bullish while ELMD’s TA Score has 5 bullish TA indicator(s).
- BDSX’s TA Score: 4 bullish, 5 bearish.
- ELMD’s TA Score: 5 bullish, 4 bearish.
Price Growth
BDSX (@Medical Specialties) experienced а -52.53% price change this week, while ELMD (@Medical/Nursing Services) price change was +1.12% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.11%. For the same industry, the average monthly price growth was -5.15%, and the average quarterly price growth was +40.44%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.05%. For the same industry, the average monthly price growth was -4.41%, and the average quarterly price growth was -2.25%.
Reported Earning Dates
BDSX is expected to report earnings on Mar 16, 2027.
ELMD is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Medical Specialties (-1.11% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+2.05% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ELMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELMD has been loosely correlated with KRMD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ELMD jumps, then KRMD could also see price increases.
| Ticker / NAME | Correlation To ELMD | 1D Price Change % | ||
|---|---|---|---|---|
| ELMD | 100% | -0.40% | ||
| KRMD - ELMD | 34% Loosely correlated | +4.53% | ||
| SMTI - ELMD | 32% Poorly correlated | +1.74% | ||
| INBS - ELMD | 31% Poorly correlated | +16.24% | ||
| RVTY - ELMD | 30% Poorly correlated | +3.62% | ||
| BDSX - ELMD | 30% Poorly correlated | +21.22% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLKR | 47.18 | 1.71 | +3.76% |
| Franklin FTSE South Korea ETF (FLKR) | |||
| BYRE | 27.59 | 0.54 | +1.99% |
| Principal Real Estate Active Opportunities ETF (BYRE) | |||
| JXI | 84.42 | 1.61 | +1.94% |
| iShares Global Utilities ETF (JXI) | |||
| RCGE | 31.34 | 0.55 | +1.79% |
| RockCreek Global Equality ETF (RCGE) | |||
| CRY | 13.69 | -0.12 | -0.90% |
| GraniteShares YieldBOOST CRCL ETF (CRY) | |||